ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $88,000 | -7.4% | 17,873 | 0.0% | 0.00% | – |
| Q2 2021 | $95,000 | +10.5% | 17,873 | 0.0% | 0.00% | – |
| Q1 2021 | $86,000 | +10.3% | 17,873 | 0.0% | 0.00% | – |
| Q4 2020 | $78,000 | +5.4% | 17,873 | 0.0% | 0.00% | – |
| Q3 2020 | $74,000 | -46.0% | 17,873 | -62.2% | 0.00% | – |
| Q1 2020 | $137,000 | -23.0% | 47,230 | +0.6% | 0.00% | – |
| Q4 2019 | $178,000 | -26.1% | 46,928 | 0.0% | 0.00% | – |
| Q3 2019 | $241,000 | -17.2% | 46,928 | 0.0% | 0.00% | – |
| Q2 2019 | $291,000 | -4.0% | 46,928 | +10.3% | 0.00% | – |
| Q1 2019 | $303,000 | -29.7% | 42,547 | -15.6% | 0.00% | – |
| Q4 2018 | $431,000 | -55.7% | 50,432 | +3.9% | 0.00% | -100.0% |
| Q3 2018 | $972,000 | -23.0% | 48,542 | -0.6% | 0.00% | 0.0% |
| Q2 2018 | $1,262,000 | +48.6% | 48,857 | +37.7% | 0.00% | 0.0% |
| Q1 2018 | $849,000 | -18.4% | 35,490 | +15.6% | 0.00% | 0.0% |
| Q4 2017 | $1,041,000 | +78.9% | 30,690 | +11.7% | 0.00% | 0.0% |
| Q3 2017 | $582,000 | +21.0% | 27,472 | 0.0% | 0.00% | – |
| Q2 2017 | $481,000 | 0.0% | 27,472 | 0.0% | 0.00% | – |
| Q1 2017 | $481,000 | +3.4% | 27,472 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $465,000 | +3.1% | 27,472 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $451,000 | +8.4% | 27,472 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $416,000 | +40.1% | 27,472 | +34.2% | 0.00% | – |
| Q1 2016 | $297,000 | -26.7% | 20,472 | +43.4% | 0.00% | -100.0% |
| Q4 2015 | $405,000 | +69.5% | 14,272 | 0.0% | 0.00% | – |
| Q3 2015 | $239,000 | -36.3% | 14,272 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $375,000 | – | 14,272 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|